Abstract
Following the identification and subsequent cloning of the gene that is defective in patients with cystic fibrosis (CF), there has been a substantial effort to evaluate gene therapy as a modality for treating this disease. As the primary cause of mortality in CF is respiratory dysfunction, the lung has been the major focus for genetic therapy intervention. Although this organ is relatively accessible for gene transduction-for example, by use of aerosols-it has become evident that there are several barriers to efficient transduction of the airway epithelia. These barriers are often further exacerbated in a diseased CF lung.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Marshall, J., Yew, N. S., Eastman, S. J., Jiang, C., Scheule, R. K., and Cheng, S. H. (1999) Cationic lipid-mediated gene delivery to the airways, in Non-Viral Vectors for Gene Therapy (Huang, L., Hung, M.-C., and Wagner, E., eds.), Academic Press, San Diego, CA, pp. 39–68.
Caplen, N. J., Alton, E. W. F. W., Middleton, P. G., Dorin, J. R., Stevenson, B. J., Gao, X., et al. (1995) Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Nature Med. 1, 39–46.
Gill, D. R., Southern, K. W., Mofford, K. A., Seddon, T., Huang, L., Sorgi, F., et al. (1997) A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 4, 199–209.
Porteus, D. J., Dorin, J. R., McLachlan, G., Davidson-Smith, H., Stevenson, B. J., Carothers, A. D., et al. (1997) Evidence for the safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis. Gene Ther. 4, 210–218.
Zabner, J., Cheng, S. H., Meeker, D., Launspach, J., Balfour, R., Perricone, M. A., et al. (1997) Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo. J. Clin. Invest. 100, 1529–1537.
Alton, E. W. F. W., Stern, F., Farley, R., Jaffe, A., Chadwick, S. L., Phillips, J., et al. (1999) Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trial. Lancet 353, 947–954.
Marshall, J., Nietupski, J. B., Lee, E. R., Siegel, C. S., Rafter, P. W., Rudginsky, S. A., et al. (2000) Cationic lipid structure and formulation considerations for optimal gene transfection of the lung. J. Drug Targeting. 7 (6), 453–469.
Geall, A. J., Taylor, R. J., Earll, M. E., Eaton, M. A. W., and Blagbrough, I. S. (2000) Synthesis of cholesteryl polyamine carbamates: pKa studies and condensation of calf thymus DNA. Bioconjugate Chem. 11, 314–326.
Eastman, S. J., Siegel, C., Tousignant, J. D., Smith, A. E., Cheng, S. H., and Scheule, R. K. (1997) Biophysical characterization of cationic lipid:DNA complexes. Biochim. Biophys. Acta 1325, 41–62.
Eastman, S. J., Tousignant, J. D., Lukason, M. J., Murray, H., Siegel, C. S., Constantino, P., et al. (1997) Optimization of formulations and conditions for the aerosol delivery of functional cationic lipid:DNA complexes. Hum. Gene Ther. 8, 313–322.
Eastman, S. J., Lukason, M. J., Tousignant, J. D., Murray, H., Lane, M. D., St. George, J. A., et al. (1997) A concentrated and stable aerosol formulation of cationic lipid:DNA complexes giving high-level gene expression in mouse lung. Hum. Gene Ther. 8, 765–773.
Fisher, K. and Branton, D. (1974) Application of the freeze-fracture technique to natural membranes. Meths. Enzymol. 32, 35–44.
Cheng, S. H. and Scheule, R. K. (1998) Airway delivery of cationic lipid:DNA complexes for cystic fibrosis. Adv. Drug Delivery Rev. 30, 173–184.
Eastman, S. J., Tousignant, J. D., Lukason, M. J., Chu, Q., Cheng, S. H., and Scheule, R. K. (1998) Aerosolization of cationic lipid:pDNA complexes-in vitro optimization of nebulizer parameters for human clinical trials. Hum. Gene Ther. 9, 43–52.
Mercer, T. T., Tillery, M. I., and Chow, H. Y. (1968) Operating characteristics of some compressed-air nebulizers. Am. Ind. Hyg. Assoc. 29, 66–78.
Dennis, J. H., Stenton, S. C., Beach, J. R., Avery, A. J., Walters, E. H., and Hendrick, D. J. (1990) Jet and ultrasonic nebulizer output: use of a new method for direct measurement of aerosol output. Thorax 45, 728–732.
Lee, E. R., Marshall, J., Siegel, C. S., Jiang, C., Yew, N. S., Nichols, M. R., et al. (1996) Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung. Hum. Gene Ther. 7, 1701–1717.
Jiang, C., O’Connor, S. P., Fang, S. L., Wang, K. X., Marshall, J., Williams, J. L., et al. (1998) Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo. Hum. Gene Ther. 9, 1531–1542.
Scheule, R. K., St. George, J. A., Bagley, R. G., Marshall, J., Kaplan, J. M., Akita, G. Y., et al. (1997) Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum. Gene Ther. 8, 689–707.
Cullen, B. R. and Malim, M. H. (1992) Secreted placental alkaline phosphatase as a eukaryotic reporter gene. Meths. Enzymol. 216, 362–368.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Humana Press Inc.
About this protocol
Cite this protocol
Marshall, J., H. Cheng, S. (2002). Formulation of Synthetic Vectors for Cystic Fibrosis Gene Therapy. In: Skach, W.R. (eds) Cystic Fibrosis Methods and Protocols. Methods in Molecular Medicine™, vol 70. Humana Press. https://doi.org/10.1385/1-59259-187-6:585
Download citation
DOI: https://doi.org/10.1385/1-59259-187-6:585
Publisher Name: Humana Press
Print ISBN: 978-0-89603-897-4
Online ISBN: 978-1-59259-187-9
eBook Packages: Springer Protocols